Christopher Egan - 17 Sep 2021 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Sep 2021, 20:01:18 UTC
Prior SEC filing
15 Sep 2021
Next SEC filing
24 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher Egan

Key filing fact

Christopher Egan filed Form 4 for Definitive Healthcare Corp. (DH) on 21 Sep 2021.

Key facts

  • This page summarizes Christopher Egan's Form 4 filing for Definitive Healthcare Corp. (DH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Sep 2021, 20:01.

Change

  • Previous filing in this sequence was filed on 15 Sep 2021.
  • Current net transaction value: -$37,893,648.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DH transaction

Class A Common Stock

Disposed to Issuer

Transaction value
$37,893,648
Shares
-1,497,033
Change %
-2.3%
Price
$25.31
Shares after
64,596,549
Date
17 Sep 2021
Ownership
See Notes
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

See Exhibit 99.1 for text of footnote (1).

Footnote F2

See Exhibit 99.1 for text of footnote (2).

Footnote F3

See Exhibit 99.1 for text of footnote (3).

Footnote F4

See Exhibit 99.1 for text of footnote (4).

SEC remarks

Exhibit 99.1 (Footnotes to Form 4) is incorporated by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .